Variational AI’s Enki™ generative AI platform designed novel ATR/mTOR dual inhibitors with brain penetrance and activity in PTEN-deficient tumor...
Vous n'êtes pas connecté
Maroc - ZACKS.COM - All Stories - 08/Nov 06:15
CVKD: Acquires Factor XIa Inhibitors???
Variational AI’s Enki™ generative AI platform designed novel ATR/mTOR dual inhibitors with brain penetrance and activity in PTEN-deficient tumor...
Ropes & Gray has advised Akebia Therapeutics on the deal. Akebia Therapeutics has announced the acquisition of Q32 Bio’s Phase 2 complement...
DelveInsight’s, “Spleen Tyrosine Kinase (SYK) Inhibitors Pipeline Insight, 2025,” report provides comprehensive insights about 10+...
Updated Date: Mon, 24 Nov 2025 00:00:00 EST
Updated Date: Mon, 24 Nov 2025 00:00:00 EST
Updated Date: Tue, 25 Nov 2025 00:00:00 EST
Updated Date: Tue, 25 Nov 2025 00:00:00 EST